Synereca Pharmaceuticals
Chapel Hill
About Synereca Pharmaceuticals
Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. Its portfolio includes prototypic RecA inhibitors, which target various pathogenic bacteria/E. coli, including those responsible for lung, urinary tract, and skin infections, as well as weaponizable gram-positive and gram-negative pathogens through various bactericidal antibiotics. The company was incorporated in 2009 and is based in Chapel Hill, North Carolina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.3M
- Last round: Series Unknown (Aug 2015)
- Website: synereca.com
- Phone: 919-929-5167
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/synereca-pharmaceuticals-2654345 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.